Breast cancer carcinoma-associated fibroblasts differ from breast fibroblasts in immunological and extracellular matrix regulating pathways
- PMID: 27112989
- DOI: 10.1016/j.yexcr.2016.04.016
Breast cancer carcinoma-associated fibroblasts differ from breast fibroblasts in immunological and extracellular matrix regulating pathways
Abstract
Tumor stroma has been recently shown to play a crucial role in the development of breast cancer. Since the origin of the stromal cells in the tumor is unknown, we have examined differences and similarities between three stromal cell types of mesenchymal origin, namely carcinoma associated fibroblasts from breast tumor (CAFs), fibroblasts from normal breast area (NFs) and bone marrow derived mesenchymal stromal cells (MSCs). In a microarray analysis, immunological, developmental and extracellular matrix -related pathways were over-represented in CAFs when compared to NFs (p<0.001). Under hypoxic conditions, the expression levels of pyruvate dehydrogenase kinase-1 (PDK1) and pyruvate dehydrogenase kinase-4 (PDK4) were lower in CAFs when compared to NFs (fold changes 0.6 and 0.4, respectively). In normoxia, when compared to NFs, CAFs displayed increased expression of glucose transporter 1 (GLUT-1) and PDK1 (fold changes 1.5 and 1.3, respectively). With respect to the assessed surface markers, only CD105 was expressed differently in MSCs when compared to fibroblasts, being more often expressed on MSCs. Cells with myofibroblast features were present in both NF and CAF samples. We conclude, that CAFs differ distinctly from NFs at the gene expression level, this hypothesis was also tested in silico for other available gene expression data.
Keywords: Breast cancer; Carcinoma-associated fibroblast; Hypoxia; Mesenchymal stromal cell; Microarray; Myofibroblast.
Copyright © 2016 Elsevier Inc. All rights reserved.
Similar articles
-
Gene expression profile of normal and cancer-associated fibroblasts according to intratumoral inflammatory cells phenotype from breast cancer tissue.Mol Carcinog. 2016 Nov;55(11):1489-1502. doi: 10.1002/mc.22403. Epub 2015 Sep 9. Mol Carcinog. 2016. PMID: 26349857
-
Activation of Transforming Growth Factor Beta 1 Signaling in Gastric Cancer-associated Fibroblasts Increases Their Motility, via Expression of Rhomboid 5 Homolog 2, and Ability to Induce Invasiveness of Gastric Cancer Cells.Gastroenterology. 2017 Jul;153(1):191-204.e16. doi: 10.1053/j.gastro.2017.03.046. Epub 2017 Apr 5. Gastroenterology. 2017. PMID: 28390866
-
Exosome-mediated delivery of miR-9 induces cancer-associated fibroblast-like properties in human breast fibroblasts.Cell Death Dis. 2016 Jul 28;7(7):e2312. doi: 10.1038/cddis.2016.224. Cell Death Dis. 2016. PMID: 27468688 Free PMC article.
-
The roles of tumor- and metastasis-promoting carcinoma-associated fibroblasts in human carcinomas.Cell Tissue Res. 2016 Sep;365(3):675-89. doi: 10.1007/s00441-016-2471-1. Epub 2016 Aug 10. Cell Tissue Res. 2016. PMID: 27506216 Review.
-
Fibrosis and cancer: A strained relationship.Biochim Biophys Acta Rev Cancer. 2020 Apr;1873(2):188356. doi: 10.1016/j.bbcan.2020.188356. Epub 2020 Mar 5. Biochim Biophys Acta Rev Cancer. 2020. PMID: 32147542 Free PMC article. Review.
Cited by
-
Dimension reduction, cell clustering, and cell-cell communication inference for single-cell transcriptomics with DcjComm.Genome Biol. 2024 Sep 9;25(1):241. doi: 10.1186/s13059-024-03385-6. Genome Biol. 2024. PMID: 39252099 Free PMC article.
-
Evaluation of blood supply and metabolism in tumor, axillary lymph node and normal breast tissue with F-18 FDG PET/CT in breast cancer: comparison with pathological prognostic factors.BMC Womens Health. 2024 Jan 16;24(1):45. doi: 10.1186/s12905-023-02858-3. BMC Womens Health. 2024. PMID: 38229093 Free PMC article.
-
Dynamic Cancer Cell Heterogeneity: Diagnostic and Therapeutic Implications.Cancers (Basel). 2022 Jan 7;14(2):280. doi: 10.3390/cancers14020280. Cancers (Basel). 2022. PMID: 35053446 Free PMC article. Review.
-
Type IV Collagen in Human Colorectal Liver Metastases-Cellular Origin and a Circulating Biomarker.Cancers (Basel). 2022 Jul 13;14(14):3396. doi: 10.3390/cancers14143396. Cancers (Basel). 2022. PMID: 35884455 Free PMC article.
-
CD105 expression in cancer-associated fibroblasts: a biomarker for bone metastasis in early invasive ductal breast cancer patients.Front Cell Dev Biol. 2023 Aug 31;11:1250869. doi: 10.3389/fcell.2023.1250869. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 37719885 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous